Several studies have reported high levels of inflammatory biomarkers in hypertension, but data coming from the general population are sparse, and sex differences have been little explored. The CoLaus Study is a cross-sectional examination survey in a random sample of 6067 Caucasians aged 35 --75 years in Lausanne, Switzerland. Blood pressure (BP) was assessed using a validated oscillometric device. Anthropometric parameters were also measured, including body composition, using electrical bioimpedance. Crude serum levels of interleukin-6 (IL-6), tumor necrosis factor a (TNF-a) and ultrasensitive C-reactive protein (hsCRP) were positively and IL-1b (IL-1b) negatively (Po0.001 for all values), associated with BP. For IL-6, IL-1b and TNF-a, the association disappeared in multivariable analysis, largely explained by differences in age and body mass index, in particular fat mass. On the contrary, hsCRP remained independently and positively associated with systolic (b (95% confidence interval): 1.15 (0.64; 1.65); Po0.001) and diastolic (0.75 (0.42; 1.08); Po0.001) BP. Relationships of hsCRP, IL-6 and TNF-a with BP tended to be stronger in women than in men, partly related to the difference in fat mass, yet the interaction between sex and IL-6 persisted after correction for all tested confounders. In the general population, the associations between inflammatory biomarkers and rising levels of BP are mainly driven by age and fat mass. The stronger associations in women suggest that sex differences might exist in the complex interplay between BP and inflammation.
INTRODUCTION
Over the last decade, hypertension has been associated with many circulating inflammatory biomarkers, promoting the idea that hypertension is an inflammatory disorder. 1 Cross-sectional studies have related hypertension and raising categories of blood pressure (BP) to, amongst others, ultrasensitive C-reactive protein (hsCRP), tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6) and IL-1b (IL-1b). 2 --5 Moreover, longitudinal studies have shown that elevated inflammatory biomarkers (mainly hsCRP) are associated with increased risk of hypertension in normotensive individuals. 6, 7 However, these data are mainly derived from selected groups (health care professionals and elderly) and data from the general population are sparse. 3, 8 In addition, sex differences have been little explored in these studies.
Overall, little is known about levels of circulating inflammatory cytokines in healthy men and women, and about potential sex differences across the entire BP range. The goal of this study was thus to explore the associations of TNF-a, IL-1b, IL-6 and hsCRP with systolic and diastolic BP in an adult general population.
PARTICIPANTS AND METHODS Recruitment
The CoLaus Study is a cross-sectional study aimed at assessing the prevalence and deciphering the molecular determinants of cardiovascular risk factors in the Caucasian population of Lausanne, Switzerland, a town of 117 161 inhabitants, of which 79 420 are of a Swiss nationality. The sampling procedure of the CoLaus Study has been described previously. 9 Briefly, the complete list of Lausanne inhabitants aged 35 --75 years (n ¼ 56 694) was provided by the population registry of the city. A simple, non-stratified random sample of 35% of the overall population was drawn. The following inclusion criteria were applied: (a) written informed consent; (b) age 35 --75 years; (c) willingness to take part in the examination and donate blood sample and (d) Caucasian origin, defined as having both parents and grandparents born in a restricted list of countries (available from the authors). The CoLaus Study was approved by the Institutional Ethics Committee of the University of Lausanne. Recruitment began in June 2003 and ended in May 2006. Participation rate was 41%.
All participants attended the outpatient clinic of the University Hospital of Lausanne in the morning after an overnight fast. They were asked to continue their usual medication intake. Data were collected by trained field interviewers in a single visit lasting about 60 min.
The examination included a detailed questionnaire, anthropometric measures and laboratory testing. Smoking was defined as present if the participant reported to be current smoker at the time of examination. BP was measured three times on the left arm using a clinically validated automatic oscillometric device (Omron HEM-907, Omron, Matsusaka, Japan) after a period of 10-min rest in the sitting position and using the appropriate cuff size. The average of the second and third values was used for analysis. Hypertension was defined as mean systolic BP (SBP) X140 mm Hg or mean diastolic BP (DBP) X90 mm Hg or the presence of antihypertensive medication. Body weight and height were measured with participants standing without shoes in light indoor clothes. Body weight was measured in kilograms to the nearest 100 g using a Seca scale (Seca, Hamburg, Germany), which was calibrated regularly. Height was measured to the nearest 5 mm using a Seca height gauge. Body mass index (BMI) was defined as weight/height 2 . Waist and hip circumferences were measured as recommended. 10 Fat mass was assessed by electrical bioimpedance using the Bodystat 1500 analyzer (Bodystat Limited, Isle of Man, British Isles). A diagnosis of diabetes was made if fasting serum glucose was 47.0 mmol l À1 or in the presence of oral hypoglycaemic or insulin treatment.
Biological data
Venous blood samples were drawn after an overnight fast. Creatinine was measured using the Jaffe kinetic compensated method (Roche Diagnostics, Rotkreuz, Switzerland). Estimated glomerular filtration rate was calculated with the CKD-EPI formula. 11 Serum cytokine levels were measured using a multiplexed particle-based flow cytometric cytokine assay. Milliplex kits were purchased from Millipore (Zug, Switzerland). This methodology yields cytokine concentrations, which correlate well with those obtained by other methods such as enzyme-linked immunosorbent assay. 12, 13 The analysis was conducted using a conventional flow cytometer (FC500 MPL, Beckman Coulter, Nyon, Switzerland). Lower detection limits for IL-1b, IL-6 and TNF-a were 0.2 pg ml À1 . Intra-and inter-assay coefficients of variation were 15% and 16.7% for IL-1b, 16.9% and 16.1% for Il-6 and 12.5% and 13.5% for TNF-a, respectively. These values were lower than other coefficient of variations previously reported in the literature.
14 For quality control, repeated measurements were conducted for 80 subjects randomly drawn from the initial sample. The following results were found for the reproducibility of the duplicate cytokine assessments: Spearman's rank correlations for IL-1b, IL-6 and TNF-a were 0.91, 0.96 and 0.89, respectively; Lin's correlation coefficients were 0.97, 0.97 and 0.95, and intra-class correlation coefficients were 0.97, 0.97 and 0.95 (all: Po0.005).
Statistical analysis
Statistical analysis was conducted using STATA 11.0 (StataCorp, College Station, TX, USA). Quantitative variables were expressed as mean ± s.d., and qualitative variables as the number of participants and percentage. Cytokines were presented as median and interquartile range. When performing quantitative analyses, the value of 0.133 pg ml À1 was attributed to undetectable values of IL-1b, TNF-a and IL-6, which corresponds to two thirds of the lower detection limit. 15 In sensitivity analyses, undetectable values of cytokines were included in the first quintile, excluded, or replaced by one half of the lower detection limit. A value of 15/10 mm Hg was added to the systolic/diastolic BP in participants on antihypertensive treatment, when performing analyses using the continuous BP traits. These values have been previously used to correct for the effect of antihypertensive treatment. 16 Between groups comparisons were performed using Student's t-test or Kruskall --Wallis nonparametric test for quantitative, and w 2 -test for qualitative variables. The relationships between cytokine values and BP (SBP and DBP) were assessed using Spearman's rank correlation. Stepwise forward multivariable linear regression, adjusting for age, sex, smoking, BMI, diabetes, lipid-lowering treatment, high-density lipoprotein and low-density lipoprotein cholesterol, as well as other cytokines, was used to determine the independent association of SBP and DBP with each log-transformed biomarker. SBP and DBP were the regressor variables, and the biomarkers were defined as the dependent variables of interest in these analyses. We tested for the presence of an interaction between sex-and logtransformed cytokine levels for their effect on BP using a multiplicative term (the product of sex-and log-transformed inflammatory marker) in the model. As some of these interactions were significant, we also performed linear regression analyses stratified by sex. Similarly, we used logistic regression to analyze the associations of the log-transformed cytokines (independent variable of interest) with hypertension as the dependant variable. Results of the logistic regression are presented as odds ratio and 95% confidence interval, and those of linear regression as b-coefficients and their 95% confidence interval. Statistical significance was considered for a two-sided Po0.05. In sensitivity analyses, we further added alcohol intake, prevalent cardiovascular disease, aspirin treatment, adiponectin levels, waist circumference and waist-to-hip ratio as covariates in the models to explore whether these variables could explain part of (the sex difference in) the association of cytokines with BP or hypertension. We also tested for an interaction between menopausal status and cytokines for their effects on BP in women.
RESULTS

Clinical characteristics
Of the 6184 initial participants, 6067 (98.1%) had their cytokines assessed; 2280 (37.6%), 446 (7.4%) and 39 (0.6%) had IL-1b, IL-6 and TNF-a levels below detection limits, respectively. Their clinical characteristics, overall, by hypertension status and by sex are summarized in Table 1 . Overall, 52.5% were women, 35.9% suffered from hypertension, 1.8% from coronary artery disease and 1.1% had a history of stroke. Participants suffering from hypertension had a history of stroke in 2.3% and of coronary artery disease in 4.2% of cases. More than half of hypertensive patients were treated with antihypertensive drugs, mainly angiotensin receptor blockers (40.4%) and diuretics (37.7%).
Distribution of cytokine levels
The distribution of serum hsCRP, IL-1b, IL-6 and TNF-a values across levels of systolic BP is shown in Table 2 . Serum concentrations of hsCRP, TNF-a and IL-6 increased across quintiles of BP, while IL-1b decreased.
Age-and treatment-adjusted systolic and diastolic BP levels increased more in women than in men from the lowest to the highest quintile of cytokine levels (P-value for trend o0.05). SBP levels decreased less in women than in men over IL-1b quintiles. The same trends were observed for DBP.
Relations between inflammatory markers and BP
The results of the crude and multivariable linear regression of logtransformed biomarkers on SBP are summarized in Table 3 . Overall, in crude analyses, all biomarkers correlated positively with SBP, except IL-1b, which correlated negatively. HsCRP remained independently associated with SBP after adjusting for age, sex, smoking, BMI, diabetes, lipids and lipid-lowering treatment whereas associations between TNF-a, IL-1b, IL-6 and SBP were no longer significant in the fully adjusted models. The same trends were observed for the associations between inflammatory markers and DBP (Supplementary Table 1) , similar results were obtained in sensitivity analyses when excluding participants on antihypertensive treatment, when excluding undetectable values of cytokines, when including undetectable values in the first quintile or when replacing them by one half of the lower detection limit (data not shown).
As shown in Table 3 , age and BMI had the strongest impact on the association between inflammatory biomarkers and SBP. The attenuation of the associations between cytokines and SBP attributable to BMI was mainly due to fat mass and not to height; beside, waist circumference, a proxy for central obesity, attenuated the cytokine --SBP association to almost the same extent as BMI ( Figure 1 ). Further adjustment for alcohol intake, prevalent cardiovascular disease, aspirin treatment and adiponectin levels did not significantly alter the associations between inflammatory markers and SBP.
In sex-stratified multivariable linear regression analyses, associations of SBP or DBP with hsCRP, TNF-a and IL-6 tended to be stronger in women than in men (Table 3) .
The interaction between sex-and log-transformed cytokine levels for their effect on BP was further tested using a multiplicative term (the product of sex-and log-transformed inflammatory marker) in the linear multivariable regression model. In this model, significant sex Â hsCRP, sex Â TNF-a and sex Â IL-6 interactions were found for SBP and DBP. Regarding SBP, the sex Â hsCRP and sex Â TNF-a interactions disappeared upon adjustment for BMI (Table 3 and Figure 2 ), while the sex Â IL-6 interaction persisted even after adjustment for all covariates (Table 3) . Regarding DBP, both the sex Â hsCRP and the sex Â IL-6 interactions disappeared upon adjustment for BMI (Supplementary Table 1 ). The attenuating effect of BMI on the sex Â cytokine interaction was largely explained by fat mass. As such, the ageadjusted regression coefficient (expressed as b (95% confidence interval, P-value)) reflecting the relationship between the sex Â hsCRP interaction and SBP decreased from 1.56 (0.65; 2.48, P ¼ 0.001) to 0.72 (À0.17; 1.61, P ¼ 0.11) after adjustment for BMI, to 0.84 (À0.07; 1.75, P ¼ 0.07) after adjustment for fat mass expressed in kg and to 0.93 (0.23; 1.85, P ¼ 0.05) after adjustment for fat mass expressed in percentage. Cytokine levels over quintiles of fat mass (expressed in kg or percentage) are shown in the Supplementary Tables 2 and 3 and showed similar trends. Similarly, the age-adjusted b-coefficient between the sex Â IL-6 interaction and SBP decreased from 1.14 (0.35; 1.92, P ¼ 0.005) to 0.78 (0.02; 1.54, P ¼ 0.04) after adjustment for BMI, to 0.89 (0.12; 1.67, P ¼ 0.02) after adjustment for fat mass in kg and to 0.98 (0.21 --1.76, P ¼ 0.01) after adjusting for the percentage of fat mass.
The differences between women and men concerning the hsCRP --BP and the IL-6 --BP relationships were not due to a difference in waist circumference, waist-to-hip ratio, alcohol intake, aspirin treatment, prevalent cardiovascular disease or adiponectin levels, as adding them as covariates in the model did not substantially alter the interaction effect between sex and cytokines. There was no significant interaction between logtransformed hsCRP and menopausal status for their effect on SBP or DBP (data not shown). 
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Results of multivariate logistic analysis with hypertension as the dependent variable are shown in Supplementary Table 4 . Overall, hsCRP was significantly and independently associated with hypertension but, in the fully adjusted models, this was only true in women. The interaction between sex and log-hsCRP was no longer significant upon adjustment for BMI, suggesting that part of the sex difference may be attributable to BMI. TNF-a and IL-6 were independently associated with hypertension in women, irrespective of age; this association disappeared upon adjustment for BMI. Finally, an inverse association was found between IL-1b and hypertension in men, whereas no association was found in women. In a sensitivity analysis excluding cytokine levels X95th percentile, the associations between log-transformed cytokine levels and SBP were as strong as those including all cytokine levels (Supplementary Table 5 ).
DISCUSSION
The main findings of this population-based study were as follows: (1) serum levels of hsCRP, TNF-a and IL-6 were positively associated with BP levels, whereas IL-1b correlated negatively with BP; (2) after adjustment for potential confounders, hsCRP remained positively and independently associated with SBP and DBP, and TNF-a remained positively associated with SBP; (3) the associations between BP and inflammatory biomarkers were substantially attenuated upon adjustment for obesity markers, namely BMI, and in particular fat mass; and (4) associations between inflammatory biomarkers (except for IL-1b) and BP tended to be stronger in women than in men. This is, to the best of our knowledge, one of the largest studies so far to examine the relationship between circulating inflammatory cytokines and BP, and one of the first to systematically On the x axis, adjustments performed for age and sex in the left column (age), for age, sex and BMI in the second column (BMI), for age, sex and fat mass (measured by bioimpedance) in the third column (fat mass), and for age, sex and waist circumference, respectively, height in the fourth and fifth column.
explore differences between men and women. As in previous cross-sectional studies, 2, 17, 18 hsCRP was positively associated with SBP and DBP levels, independently of diabetes, smoking, BMI and kidney function. TNF-a was positively and independently associated with SBP but not with DBP, partly confirming previous studies that found a positive association between BP and TNF-a. 2, 3 As such, this study supports the theory that increased BP is associated with (vascular) inflammation. 1 The interplay between hypertension and inflammation is complex and occurs in both directions, although the evidence of increased levels of biomarkers preceding the development of hypertension is more established. For instance, the population-based ATTICA study found inflammatory markers, such as hsCRP and TNF-a, to be already increased in prehypertensive individuals, 2 and the prospective Women's Health Study showed that raised hsCRP levels preceded, and were a risk factor for, the development of essential hypertension. 7 A positive association between IL-6 and BP was found. However, in contrast to former smaller sized studies, 3, 4 but in accordance with another recent study, 19 this association disappeared after adjustment for BMI. The attenuation of the association between IL-6 and BP, after adjustment for BMI, suggests that the adipose tissue lies in the causal pathway between inflammatory cytokines and BP. Indeed, the adipose tissue is the main source of TNF-a, and produces B30% of the circulating IL-6. 20, 21 In turn, TNF-a and IL-6 stimulate the production of CRP by the liver. 22 Moreover, the association between obesity and inflammatory markers has been thoroughly studied over the last decade, and is well documented. 23 --25 It therefore appears logical that associations between BP and biomarkers were attenuated upon adjustment for BMI in our study. We were able to show that the BMI effect was attributable mainly to fat mass (as measured by electrical bioimpedance) and not to height. Beside, the attenuative effect of waist circumference suggests that the BMI effect is merely driven by abdominal (visceral) adiposity and less by peripheral adiposity. Previous studies 3, 4 have neither specifically explored the role of body fat in these associations, nor were as large 26 nor were truly populationbased. 27 Another possible explanation for the discrepancy with former studies might be the differences in laboratory technique used for cytokine-dosing: previous studies have mainly used the enzyme-linked immunosorbent assay technique (R&D Systems Europe Ltd, Abingdon, UK or IMMULITE, Siemens Healthcare Diagnostics, Tarrytown, NY, USA), whereas in this study, flow cytometric assays were used. The enzyme-linked immunosorbent assay of R&D has a detecting range for IL-6 from 0.156 to 10 pg ml
À1
, the IMMULITE assay a lower detection limit of 5 pg ml À1 , 2,3 whereas the flow cytometry technique used in this study has a detection range from 0.2 to 5000 pg ml À1 . Hence, because of the high upper detection limit, inter-individual variability was larger compared to other studies. 28, 29 Beside, a rather high proportion of participants had undetectable (o0.2 pg ml À1 ) levels of IL-1b. In other studies, the issue of undetectable values has not always been clearly discussed, thus compromising between-study comparisons. In this study, an arbitrary value of 0.133 (2/3 of the lower detection limit) was attributed to subjects with undetectable levels. 15 Other methods (analysis on quintiles, use of 1/2 instead of 2/3 of lower detection limit, exclusion of individuals with undetectable values) led to similar (nonsignificant) results for the association between IL-1b and BP. However, in contrast to this study, previous cross-sectional studies have reported increased levels of IL-1b in the systemic circulation of patients with essential hypertension and positive associations with BP. 30, 31 Moreover, human atherosclerotic lesions contain high levels of IL-1b, 32 and animal studies have shown that IL-1b has an active role in BP regulation. 33 These data underline the important role of IL-1b in the cardiovascular system, despite the negative findings in this study. Taken together, the large number of undetectable values IL-1b values limits the interpretability of the results for this cytokine in our study. In general, the type of laboratory technique used for cytokine-dosing merits attention, and larger uniformity in laboratory techniques might lead to improved between-study comparisons and will improve our ability to understand the relationships between serum levels of inflammatory cytokines and associated disease states.
All biomarkers (except IL-1b) tended to be more strongly associated with BP in women than in men. Gender differences in circulating cytokine levels have been well documented and might be explained by differences in fat mass distribution, 26, 34, 35 but only very few studies have investigated correlations with BP. The Multi-Ethnic Study of Atherosclerosis study, the largest so far (n ¼ 3479 Caucasians), did not find a sex difference between hsCRP --BP associations, but other cytokines were not dosed in this study. 17 It is a well-known fact that total fat mass and percentage fat mass are generally higher in women as compared with men. 36 Also, the relationship between fat mass and inflammatory markers is usually stronger in women than in men. 26, 37 In our study, total fat mass and percent fat mass were indeed higher in women, which might have influenced the BP --cytokine associations. This was the case for hsCRP and TNF-a, yet the interaction between sex and IL-6 persisted after correction for fat mass and all potential confounders. It is possible that sex hormones have a role, as oestrogens are well-known inhibitors of IL-6. 38 However, no differences were found in the BP --biomarker relationship between pre-and postmenopausal women in this study. Finally, the functional aspects of adipose tissue might differ between men and women. As such, it is known that women develop preferentially peripheral (subcutaneous) adiposity, whereas men are more prone to abdominal (visceral) adiposity. 39 A recent observational study that used computer tomography to estimate the body fat distribution reported that the circulating level of hsCRP was mainly influenced by the amount of visceral adiposity in men, and by the amount of subcutaneous adipose tissue in women. 26 In this study, sex differences in the BP--biomarker relationship were independent of waist circumference; however, waist circumference is less adequate in visceral adiposity estimation than the gold-standard computer tomography. 40 Taken together, the reason why BP --biomarker associations were stronger in women than in men remains unclear and merits further study.
The strengths of this study include the large sample size, the availability of detailed information on several potential confounders, including drugs capable of lowering circulating levels of inflammatory markers and the high quality of cytokine dosing, resulting in good reproducibility of results. Among the limitations of this study are its cross-sectional nature, which limits causal inferences, and the relatively high proportion of undetectable values for IL-1b, which limits the interpretability of the results for this cytokine. Further, we cannot exclude that some of the higher cytokine levels were explained by (subclinical) infections (for example, body temperature was not measured and leucocyte count not performed). However, participants were instructed to postpone their appointment in case of (suspected) infection. The number of participants nevertheless presenting with underlying acute bacterial or viral infection was thus probably low. Indeed, in the ongoing follow-up of the CoLaus Study providing the same instructions to the participants body temperature is actually measured. So far, the mean body temperature in 4645 participants is 36.2 1C, and only 7 participants (0.15%) have a body temperature X37.5 1C (unpublished data). Finally, associations between BP and cytokine levels o95th percentile were as strong as those including all cytokine levels.
In conclusion, this large population-based study adds information to the growing body of evidence that links chronic low-grade inflammation to arterial hypertension. This study also shows that the association between inflammatory biomarkers and BP is stronger in women than in men and driven, in part, by fat mass, compatible with the detrimental role of overweight and obesity in hypertension. Interventional studies with lifestyle modifications are needed to evaluate if weight loss in hypertensive individuals improves their inflammatory biomarkers profile.
What is known about this subject
Hypertension is more and more considered as an inflammatory disorder, and has been linked with high-sensitivity C reactive protein (hsCRP) and other markers of inflammation. Clinical data are mostly derived from cross-sectional studies in selected groups (health-care professionals, high cardiovascular risk and elderly) and data from the general population are sparse. Beside, sex differences and associations with adipose tissue have been little explored.
What this study adds
In this large cross-sectional study (n ¼ 6067), performed in the general population of Lausanne, Switzerland, associations between the inflammatory markers interleukin (IL)-6, IL-1b, TNF-a and blood pressure (BP) were weaker than reported in previous studies; only hsCRP remained significantly associated with BP after correction for confounders.
The cytokine --BP associations were attenuated upon adjustment for fat mass (measured with electrical bio-impedance), suggesting that fat mass lies in the causal pathway, and underlining the detrimental role of overweight and obesity in hypertension. Associations were stronger in women than in men. This was only partly explained by differences in fat mass and irrespective of the menopausal status.
